IMPAX to Present at 13th Annual Wachovia Securities Nantucket Conference

June 17, 2003
Company Presentation Tuesday, June 24, at 11:15 a.m. EDT

June 17, 2003--IMPAX Laboratories, Inc. (NASDAQ: IPXL - News) today announced that management will present at the 13th Annual Wachovia Securities Nantucket Conference on Tuesday, June 24, 2003 at 11:15 a.m. EDT. The conference will be held from June 24-27, 2003 at the Harbor House Village in Nantucket, Massachusetts.

Individuals may listen to both the live and archived webcast until July 24, 2003 at the following address: In addition, a link to the live and archived presentation will be posted on the investor relations portion of the company's website at

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: